IASIC Speaker Series Presents Impaired Driving in a Climate of Cannabis Commercialization: Lessons from Colorado for the Nation

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed, organized, and guided by doctors.

Session: Impaired Driving in a Climate of Cannabis Commercialization: Lessons from Colorado for the Nation
Presented By: Robert L. DuPont, MD; Ed Wood, MBA
Date: Tuesday, March 8, 2022
Time: 1:00PM Eastern/10:00AM Pacific
Price: FREE

This session will present data on the role of cannabis in impaired driving from the state of Colorado, ground zero for cannabis commercialization. What policies have been adopted to detect and deter cannabis-impaired driving – and have they worked? The data may surprise you. In this session, Dr. Robert DuPont and Mr. Ed Wood will discuss the policy solutions that are needed at the local, state, and national levels to reduce the adverse impact of polysubstance use on our roads.

Register for this FREE Session

View Upcoming Sessions

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on Linkdin
Share on pinterest
Share on Pinterest

Leave a comment

Related Posts

What is THCP?

THCP, which is short for tetrahydrocannabiphorol and scientifically known as (-)-Trans-Δ9-tetrahydrocannabiphorol, is a natural cannabinoid and analog of THC present in varieties of cannabis. It’s thought to be 33 times more active at cannabinoid 1 (CB1) receptors than THC, causing an intense and intoxicating euphoric high. THCP’s legality is stuck between conflicting federal legislation. It’s not

Cannabis Legalization and Detection of Tetrahydrocannabinol (THC) in Injured Drivers

A recent study funded by the Canadian Institutes of Health Research found that after cannabis legalization, the prevalence of moderately injured drivers with a THC level of at least 2 ng per milliliter in participating British Columbia trauma centers more than doubled. The increase was largest among older drivers and male drivers. During the study

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol

For nearly a century, Cannabis has been stigmatized and criminalized across the globe, but in recent years, there has been a growing interest in Cannabis due to the therapeutic potential of phytocannabinoids. With this emerging interest in Cannabis, concerns have arisen about the possible contaminations of hemp with pesticides, heavy metals, microbial pathogens, and carcinogenic compounds during the cultivation, manufacturing,

Scroll to Top